Subbu Nambi's Stock Ratings

Guggenheim Analyst

Subbu Nambi is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024

Overall Average Return

-2.13%

Smart Score

45.6%

Overall Average Return Percentile

33rd

Number of Ratings

17
Buy NowGet Alert
06/28/2024GHBuy Now
Guardant Health
$27.6030.42% → $36UpgradeNeutral → BuyGet Alert
06/27/2024SOPHBuy Now
Sophia Genetics
$4.5033.33% → $6Initiates → BuyGet Alert
06/27/2024NAUTBuy Now
Nautilus Biotechnology
$2.28163.16% → $6Initiates → BuyGet Alert
06/26/2024TXGBuy Now
10x Genomics
$18.45DowngradeBuy → NeutralGet Alert
06/25/2024TXGBuy Now
10x Genomics
$18.45DowngradeBuy → NeutralGet Alert
06/18/2024RGENBuy Now
Repligen
$119.79Initiates → NeutralGet Alert
06/05/2024TWSTBuy Now
Twist Bioscience
$48.958.27% → $53Initiates → BuyGet Alert
04/05/2024GHBuy Now
Guardant Health
$27.60Reiterates → NeutralGet Alert
12/14/2023CSTLBuy Now
Castle Biosciences
$17.9539.28% → $25Initiates → BuyGet Alert
12/14/2023MYGNBuy Now
Myriad Genetics
$25.26-8.95% → $23Initiates → BuyGet Alert
12/14/2023GHBuy Now
Guardant Health
$27.60Initiates → NeutralGet Alert
12/14/2023NTRABuy Now
Natera
$109.52-36.08% → $70Initiates → BuyGet Alert
12/14/2023EXASBuy Now
Exact Sciences
$44.54102.07% → $90Initiates → BuyGet Alert
12/14/2023PACBBuy Now
Pacific Biosciences
$1.34Initiates → NeutralGet Alert
12/14/2023ILMNBuy Now
Illumina
$107.8543.72% → $155Initiates → BuyGet Alert
12/14/2023AKYABuy Now
Akoya Biosciences
$2.09Initiates → NeutralGet Alert
12/14/2023TXGBuy Now
10x Genomics
$18.45225.2% → $60Initiates → BuyGet Alert